Approval · Notice of Compliance 31409 · 2023
AMOXICILLIN: Notice of Compliance 31409
Issued August 14, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31409
- Date
- August 14, 2023
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Labelling Update (to match Licensor)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | Not yet assigned | — |
| AMOXICILLIN (SUGAR REDUCED) | Not yet assigned | — |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 250 MG per CAP
- AMOXICILLIN TRIHYDRATE 250 MG per 5ML
- AMOXICILLIN TRIHYDRATE 500 MG per CAP